EP2588086

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE.

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    29.6.2011
  • :
    12.9.2018
  • :
    11734043.0
  • :
    28.6.2031
  • :
    PHARMACEUTICAL COMPOSITIONS COMPRISING 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]-1H-QUINOLIN-2-ONE LACTATE MONOHYDRATE.

29.6.2011
12.9.2018
  • :
    Novartis AG
  • :
    Lichtstrasse 35, 4056, Basel, CH
  • :
    THAKUR, Jeewan
  • :
    Basel, CH
  • :
    QIU, Zhihui
  • :
    Shanghai, CN
  • :
    10168028
  • :
    30.6.2010
  • :
    EP
  • :
    EP2011060949
  • :
    29.6.2011
  • :
    A61K 9/16, A61K 9/20, A61K 31/496